Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma
2019
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
2010
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A pan-cancer study of selenoprotein genes as promising targets for cancer therapy
2021
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
2020
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
2020
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
2009
New frontiers in liver resection for hepatocellular carcinoma
2020
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation
2014
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma
2015
Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis #
2009
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
2014
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis
2016
Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma
2015
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Acute-on chronic liver failure
2012
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
2017
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Complications of Microwave Ablation for Liver Tumors: Results of a Multicenter Study
2011
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
2012
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
2014
Comparative Short-term Benefits of Laparoscopic Liver Resection
2015
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Laparoscopicvsopen approach to resection of hepatocellular carcinoma in patients with known cirrhosis: Systematic review and meta-analysis
2014
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B
2013
Are Patients with Child’s A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?
2011
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with Cirrhosis
2013
Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome
2015
Long-term outcomes of laparoscopic liver resection for hepatocellular carcinoma: A propensity score matched analysis of a high-volume North American center
2021
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Non-alcoholic fatty liver disease and liver transplantation
2016
Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience
2015
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients
2018
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
2018
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Hepatitis B virus infection
2018
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
2013
Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
2013
Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors
2017
The option of HBIG-free prophylaxis against recurrent HBV
2012
Hepatocellular Carcinoma
2011 Standout
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
2021
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
2015
A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma
2015
Hepatocellular carcinoma
2022 Standout
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
2018
Targeted Therapies for Hepatocellular Carcinoma
2011
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Assessment of Hepatic Function, Operative Candidacy, and Medical Management after Liver Resection in the Patient with Underlying Liver Disease
2013
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Excellent post‐transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy
2015
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma
2019
Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients
2017
Does the preoperative alpha‐fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?
2014
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma
2014
Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
2021
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments?
2013
Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis
2021
Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
2010
Laparoscopic vs. Open Liver Resection for Hepatocellular Carcinoma of Cirrhotic Liver: A Case–Control Study
2014
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
2011
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease
2015
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
2013
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
2013
Management of people with early- or very early-stage hepatocellular carcinoma
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues
2012
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Management of patients with hepatitis B in special populations
2015
Works of Ksh Chok being referenced
Survival Analysis of High-Intensity Focused Ultrasound Therapy Versus Radiofrequency Ablation in the Treatment of Recurrent Hepatocellular Carcinoma
2013
Treatment strategy for recurrent hepatocellular carcinoma: Salvage transplantation, repeated resection, or radiofrequency ablation?
2013
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
2018
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
2011
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong
2019
11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon’s Perspective
2013
Management of recurrent hepatocellular carcinoma after liver transplant
2015
High-Intensity Focused Ultrasound for Hepatocellular Carcinoma
2011
Long-Term Survival Analysis of Pure Laparoscopic Versus Open Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis
2013
A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation
2015
Recurrence of hepatocellular cancer after liver transplantation: The role of primary resection and salvage transplantation in East and West
2012
Incomplete Ablation After Radiofrequency Ablation of Hepatocellular Carcinoma: Analysis of Risk Factors and Prognostic Factors
2007
Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses
2019
Risk Factors and Prognostic Factors of Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma
2008
Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B
2013
Comparable Survival in Patients With Unresectable Hepatocellular Carcinoma Treated by Radiofrequency Ablation or Transarterial Chemoembolization
2006
Survival analysis of high‐intensity focused ultrasound ablation in patients with small hepatocellular carcinoma
2012
Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis
2019
Effects of the Liver Volume and Donor Steatosis on Errors in the Estimated Standard Liver Volume
2011
Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS
2016
Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5–8 cm
2014
Can positron emission tomography with the dual tracers [11C]acetate and [18F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
2011
Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular Carcinoma
2013
Wait and Transplant for Stage 2 Hepatocellular Carcinoma With Deceased-Donor Liver Grafts
2013
Evaluation of the seventh edition of the American Joint Committee on Cancer tumour–node–metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
2012
Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation
2012
Phase 2 open‐label study of single‐agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B–endemic Asian population
2008
Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation
2014
Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion
2011
Use of Liver Stiffness Measurement for Liver Resection Surgery: Correlation with Indocyanine Green Clearance Testing and Post-Operative Outcome
2013
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma
2018
Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years
2017
Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases
2012
Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis
2016
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
2017
Excellent outcomes of liver transplantation using severely steatotic grafts from brain‐dead donors
2015
Survival Analysis of Re‐resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
2011
Laparoscopic versus open liver resection for elderly patients with malignant liver tumors: A single‐center experience
2014